Receptors in aging diseases: Dopamine receptors

被引:0
|
作者
Giorgioni, G [1 ]
机构
[1] Univ Camerino, Dipartimento Sci Chim, I-62032 Camerino, Italy
关键词
D O I
10.1007/s00044-004-0015-9
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:103 / 104
页数:2
相关论文
共 50 条
  • [1] Receptors in Aging Diseases: Dopamine Receptors
    Gianfabio Giorgioni
    Medicinal Chemistry Research, 2004, 13 : 103 - 104
  • [2] Introduction to receptors in aging diseases:: GABAA receptors
    Froestl, W
    MEDICINAL CHEMISTRY RESEARCH, 2004, 13 (1-2) : 99 - 102
  • [3] Introduction to Receptors in Aging Diseases: GABA Receptors
    Wolfgang Froestl
    Medicinal Chemistry Research, 2004, 13 : 99 - 102
  • [4] Opposite role of dopamine receptors in aging
    Ioannis Bakoyiannis
    Lab Animal, 2022, 51 : 129 - 129
  • [5] Opposite role of dopamine receptors in aging
    Bakoyiannis, Ioannis
    LAB ANIMAL, 2022, 51 (05) : 129 - 129
  • [6] AGING PROCESS AFFECTS A SINGLE CLASS OF DOPAMINE RECEPTORS
    MEMO, M
    LUCCHI, L
    SPANO, PF
    TRABUCCHI, M
    BRAIN RESEARCH, 1980, 202 (02) : 488 - 492
  • [7] Research progress on the roles of dopamine and dopamine receptors in digestive system diseases
    Lu, Xianmin
    Liu, Qi
    Deng, Ya
    Wu, Jiangbo
    Mu, Xingyi
    Yang, Xiaoxu
    Zhang, Ting
    Luo, Chen
    Li, Zhuo
    Tang, Siqi
    Hu, Yanxia
    Du, Qian
    Xu, Jingyu
    Xie, Rui
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (07)
  • [8] Polymorphism of dopamine receptors and transporter genes in neuropsychiatric diseases
    Fujiwara, Y
    Yamaguchi, K
    Tanaka, Y
    Tomita, H
    Shiro, Y
    Kashihara, K
    Sato, K
    Kuroda, S
    EUROPEAN NEUROLOGY, 1997, 38 : 6 - 10
  • [9] HUMAN-BRAIN DOPAMINE-RECEPTORS IN CHILDREN AND AGING ADULTS
    SEEMAN, P
    BZOWEJ, NH
    GUAN, HC
    BERGERON, C
    BECKER, LE
    REYNOLDS, GP
    BIRD, ED
    RIEDERER, P
    JELLINGER, K
    WATANABE, S
    TOURTELLOTTE, WW
    SYNAPSE, 1987, 1 (05) : 399 - 404
  • [10] Schizophrenia and dopamine receptors
    Seeman, Philip
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 (09) : 999 - 1009